CHEMOTHERAPEUTIC TRIALS IN PSYCHOSIS: III
2-Brom-d-Lysergic Acid Diethylamide (BOL 148)
WM. J. TURNER M. D., and
SIDNEY MERLIS M. D.1
1 Research Division, Central Islip State Hospital, Central Islip, N. Y.
BOL 148 administered to chronic schizophrenics, 1 mg. t.i.d. to 6 subjects for 2 weeks, or 5 mg. q.i.d. for 3 days to 3 subjects, had no evident effect on their psychoses.